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INTRODUCTION 
 
General anaesthesia can be administered by multiple means to a patient. 
Most common method used is with the help of endotracheal intubation 
and artificially controlling a patient’s ventilation. 
 
The occurrence of major complications such as aspiration and hypoxia, 
especially in patients coming for emergency surgery, obese patients or 
cesarean section where rapid sequence induction is required, depends on 
how fast an anesthesiologist is able to secure the airway. This in turn 
depends on the onset time of proper intubating conditions. 
 
Satisfactory intubating conditions can be obtained by using multitude of 
drugs and methods. Most common method is to use an induction agent 
along with administration of suxamethonium for muscle relaxation. Even 
though suxamethonium produces excellent intubating conditions with a 
very short onset time, it has its own limitations. 
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 It is contraindicated or better avoided in patients with hyperkalemia, 
pseudocholinesterase deficiency, burns, penetrating eye injury, allergic 
reactions, increased intracranial pressure. Also, Suxamethonium induced 
muscle relaxation produces myalgia postoperatively. 
 
Rocuronium has in the recent past emerged as a useful alternative to 
suxamethonium for rapid sequence induction especially when 
suxamethonium is contraindicated. It is an aminosteroid derivative with 
very short onset of action. To use it for Rapid sequence induction it has to 
be used at thrice its ED95 dosage which leads to prolonged duration of 
action. 
 
Various strategies were devised to use a lower dose for RSI thereby 
limiting its duration of action. Priming was used in many studies without 
any conclusive results either for or against the technique. Another method 
is to reduce the effect site equilibrium time, shortening it will lead to a 
faster onset. This has been extensively studied using recirculatory 
pharmacokinetic models. Using indocyanine green as a marker it has 
been proved that cardiac output influences the pharmacokinetics of 
Rocuronium. 
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Many drugs have been given before induction to maintain or improve the 
cardiac output. Ephedrine has been used previously to increase the 
cardiac output and reduce the onset time of Rocuronium by as much as 
26%. Intubating conditions were also better with the use of Ephedrine.  
Esmolol, a beta blocker, which reduces the cardiac output, was found to 
prolong the onset time.  
Ketamine, a NMDA antagonist, has a sympathomimetic property. It has 
been used extensively as an induction agent in cases of hypovolemic 
shock. It maintains the cardiac output. In addition it has anesthetic 
properties which will help in providing better intubating conditions.  
 
Thus, we hypothesized that addition of low dose Ketamine to propofol 
Rocuronium induction will shorten the onset time and produce better 
intubating conditions. 
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AIM OF THE STUDY 
 
The aim of the study was to evaluate the effects of Ketamine and normal 
saline given before induction on the onset time and intubating conditions 
of Rocuronium bromide 
 
The parameters to be evaluated are  
 
 The onset  time of Rocuronium 
 The intubating conditions  
 Cormack lehanne grading 
 Percentage of glottis opening 
 
The secondary outcomes to be measured are  
 
 Heart rate variations  
 Hemodynamic alterations during the study 
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FUNCTIONAL ANATOMY OF NEUROMUSCULAR JUNCTION 
 
Neuromuscular junction is a specialized structure at the interface of nerve 
and muscle where the messages from the motor cortex are transmitted 
through chemical mediators. From the anterior horn of spinal cord and the 
medulla the motor neuron travels as a thick myelinated axon. In the 
muscles, it branches out to form contact with muscle to form many 
functional parts known as motor unit. Stimulation of a neuron causes all 
the muscle cells in the motor unit to contract synchronously to cause 
fasciculations. 
 
The nerve and muscle are separated by a slender distance of 20 nm. This 
portion is called synaptic cleft. The muscular surface is corrugated into 
primary and secondary clefts, thereby increasing the surface area. 
Acetylcholine receptors are situated at the shoulder of the cleft while the 
sodium channels are located deep within. 
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Perijunctional area is rich in sodium channels and here aceylcholine 
receptors are less dense.  The vesicles containing acetylcholine are 
located near electron dense thickened portion of membrane known as 
active site. Mitochondria, microtubules and other support structures are 
located on its opposite side. 
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The end plate potential is the sum total of miniature end plate potentials 
caused by release of small vesicles from the end plate. Release of vesicles 
usually occurs after a stimulus. Each stimulus releases 200 quanta. Each 
quanta contains 5000 acetylcholine molecules which can stimulate around 
five lakh molecules of acetylcholine receptors. Transmission across the 
junction has substantial margin for safety and at the same time has a lot of 
reserve. 
 
STEPS OF TRANSMISSION: 
 
1. Acetate and choline from the nerve ending form the substrate. They 
are transported into the cell where acetate is converted to aceyl 
CoA in mitochondria. Acetyl Coa in the presence of choline acetyl 
transferase binds with choline to form acetylcholine. 
 
2. This acetylcholine thus formed is stored in cytoplasm. Once 
required they are packed into vesicles and transported to the end-
plate for release. 
 
3. Once a nerve is stimulated sodium enters the cell causing 
depolarisation and release of calcium into the neurons. This causes 
the release of acetylcholine into the synaptic cleft. Calcium plays 
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an important role in nerve terminal. Accumulation of calcium can 
increase the force of contraction and can overcome neuromuscular 
blockade. This is classically seen in post-tetanic contraction. 
 
4. Other conditions such as eaten lambert syndrome and myasthenia 
gravis, where there is antibody against calcium channels, 
classically produce weakness. Magnesium and other divalent 
cations can compete with calcium and can prolong neuromuscular 
blockade. 
 
5. Synaptic release and recycling : the nerve terminal contains two 
type of vesicles VP1 (reserve vesicles) and VP2 (releasable 
pool).they are tethered to the membrane by proteins such as 
synaptobrevin, synphysin and others. binding of calcium to the 
SNARE proteins causes these vesicles to fuse with the membrane 
and release its contents. 
 
 Toxins from botulinum and tetanus block the release of vesicles by 
damaging one of the SNARE proteins. Since the release of 
acetylcholine is inhibited it leads to paralysis 
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6. Once acetylcholine is released it into the cleft, it reacts with 
receptors in the muscle end to initiate contraction. 
 
7. The acetylcholine that is not bound to the receptors, once it is 
released into the synapse, is metabolised immediately by 
acetylcholine esterase. Acetylcholine molecule is one of the most 
potent messengers in human body but its action is terminated in 
milliseconds due to the efficient activity of acetylcholine esterase. 
 
Post junctional acetylcholine receptors are of three types. They are 
 Junctional or mature 
 Extrajunctional or immature 
 Neuronal α 7 receptors. 
The acetylcholine receptor in junctional region is made of 5 subunits.it is     
attached to the membrane of the myocyte with the help of rapsin. the 
binding site of acetylcholine  is present in α subunit. The α- 7 receptor 
contains 7 alpha subunits. 
 
The acetylcholine receptor is a cylinder formed from arrangement of its 
subunit. Normally it is closed in position. once an agonist binds to the 
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both the α receptor it opens up leading to inflow of sodium, calcium and 
other neutral particles. Influx calcium leads to depolarisation and 
subsequent contraction of muscle. 
 
If a molecule binds only one α site than that channel remains closed. It 
remains unavailable for action by agonist. This is the mechanism by 
which nondepolarising muscle relaxant works. It is a competitive 
blockade and thus a function of number of molecules available. Once 
cholinesterase inhibitors are given, the ratio of acetylcholine increases in 
the synaptic cleft  and thus leads to recovery of muscle function. 
 
Suxamethonium is made of two molecules of acetylcholine. Binding of 
suxamethomnium to neuromuscular junction causes contraction. As it is 
not destroyed immediately, the sodium channel that is open for a longer 
time becomes desensitized. This leads to relaxation of muscle. 
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NEUROMUSCULAR MONITORING 
Neuromuscular junction can be monitored using a peripheral nerve 
monitor. Supramaximal stimulus is administered and various patterns are 
noted. 
 
1. Single muscle twitch 
A single stimulus lasting just 0.2 millisecond in duration is given. 
 
2. Tetanic impulse 
A prolonged stimulus of the frequency of fifty to hundred hertz 
lasting 5 milliseconds is given 
 
3. Train of four 
Four  stimuliat a frequency of two hertz each lasting 0.2 
milliseconds. 
 
4. Double burst stimulation 
3 short stimli lasting two hundred microseconds is delivered each 
separated by 0.02 seconds is given. This is followed by another two 
or three such stimuli at a interval of 0.75 seconds. 
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 Characteristics of  non-depolarizing block 
 Non depolarizing neuromuscular blockade is characterized by fade. Fade 
is the diminution of evoked potential after prolonged or repeated 
stimulation of the nerve. 
 
Absence of fade after repeated nerve stimulus correlates well with 
recovery. Double burst stimulation and post –tetanic indicate the recovery 
from the block, its better than single twitch and TOF counts. 
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PHARMACOLOGY OF ROCURONIUM 
 
STRUCTURE:  
 
It is a monoquartenary aminosteroid. Structurally it differs from 
vecuronium by the presence of hydroxyl group rather than an acetyl 
group in the A ring of steroid nucleus. 
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DOSAGE: 
Its ED95 is 0.3 mg/kg, with onset of action around 2 minutes and duration 
of blockade of 20-30 minutes. When used in dosage of 3-4 times ED95 it 
can be used at par with suxamethonium for rapid sequence induction. 
When used at such high dosage it can cause blockade like a long acting 
nondepolarizing muscle relaxant with duration of action up to 60-90 
minutes. 
Large intramuscular doses -1-8mg/kg has been used in infants and 
children to permit rapid sequence induction at the cost of longer duration 
of blockade. 
 
REASON FOR SHORTER ONSET OF ACTION: 
 
It is a drug with low potency. When large number of molecules of such a 
low potency drug is administered, greater quantity of such a drug is 
available for diffusion and binding at the neuromuscular junction. Thus, a 
rapid onset of action is more likely to be achieved. So, Rocuronium when 
given in sufficient dosage can be used for suxamethonium, when the 
latter is contraindicated. 
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INTUBATING CONDITIONS: 
 
Laryngeal adductor muscles and diaphragm are more resistant to 
neuromuscular blockade of non-depolarizing muscle relaxants
3
 when 
compared to the adductor pollicis muscle. Hence, single twitch 
suppression at the level of adductor pollicis might not produce adequate 
intubating conditions. 
When used at the dose of 0.6 mg/kg, Rocuronium does not produce good 
intubating conditions in 25% of patients.
1,5
 Many authors have reported 
that IM Rocuronium given for RSI in infants and children does not 
consistently produce good intubating conditions. 
 
OTHER PROPERTIES: 
 It does not release histamine or known to cause any allergic 
reactions. 
 It hasvagolytic properties and can be used in conditions such as 
opthalmoscopies and laparoscopies were vagal stimulation is 
present. 
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METABOLISM: 
It is not actively metabolized and is excreted unchanged in bile. As it 
doesnot have any active metabolites, it can be better choice for infusions 
in ICU set up when compared to vecuronium. 
Its duration of action is increased in liver failure and in pregnancy. 
Decreased hepatic clearance in elderly prolongs the duration of its action 
without affecting the time of its onset.  
It should be used with caution in patients with renal failure.
3
Its duration 
of action is prolonged in morbidly obese patients when the dose of the 
drug is calculated using real bodyweight rather than ideal body weight. 
 
USES: 
 
Rocuronium is a unique drug among nondepolarizing neuromuscular 
blockers with rapid onset and hence is used in RSI. 
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DRUGS AFFECTING NEUROMUSCULAR 
BLOCKADE: 
 
 VOLATILE ANAESTHETICS: 
 
 
 They produce dose dependent enhancement of blockade with 
nondepolarizing neuromuscular blockers 
 Enhancement of blockade is greatest with enflurane, 
isoflurane and sevoflurane and least with nitrous - opioid 
combinations. 
 It may be due to its central effect on CNS, which decreases 
muscle tone, or increased muscle blood flow, or decrease in 
sensitivity to depolarization in post junctional receptors. 
 Plasma concentrations required to produce suppression of 
twitch response is less in the presence of volatile 
anaesthetics. 
 
 SYMPATHOMIMETIC DRUGS: 
 
 Drugs such as Ephedrine that increase sympathetic activity 
shorten the onset of neuromuscular blockers by increasing 
the cardiac output and muscle blood flow. 
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 On the contrary, drugs such as Esmolol by decreasing 
cardiac output and lengthens the onset time. 
 
 ANTIBIOTICS 
 
 They may exert their effects by altering the prejunctional 
receptors thereby decreasing the release of acetylcholine. 
 
 LOCAL ANAESTHETICS 
 
 At smaller doses, they enhance blockade of nondepolarizing 
neuromuscular blockers, but at higher concentrations have 
antagonistic effects. 
 
 Diuretics and antiarrhythmic drugs can potentiate pre-existing 
blockade by decreasing the release of acetylcholine. 
 
 Magnesium and lithium can inhibit the release of acetylcholine by 
binding to prejunctional receptors and potentiates the activity of 
muscle relaxants. 
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PHARMACOLOGY OF KETAMINE 
 
Ketamine is a phencyclidine derivative which produces dissociative 
anaesthesia. The patient becomes cataleptic and non-communicative .It 
produces amnesia and intense analgesia. The preservative used is 
benzathonium chloride. 
It is a drug with abuse potential; hence unauthorized use has to be 
avoided. 
 
STRUCTURE ACTIVITY RELATIONSHIP 
.  
 
Ketamine is  
2-(o-chlorophenyl)-2-(methylamino) cyclohexanone 
(hydrochloride):  
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Ketamine is water soluble. It has an asymmetric carbon atom leading to 
two optical isomers, S and R Ketamine. 
 
 
 
 
 S-Ketamine produces
1
 
 more intense analgesia 
 rapid metabolism and recovery  
 less salivation and  
  lower incidence of emergence reaction 
 
 
 
S-(+)-Ketamine R-(-)-Ketamine 
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MECHANISM OF ACTION 
 
 Ketamine has an antagonist effect on NMDA receptors inhibiting 
the binding of glutamate,decreasingits presynaptic release and also 
potentiating the effect of GABA. 
 
 Ketamine has agonistic action on kappa receptors and antagonistic 
effect on mu receptors. 
 
 It may inhibit descending monoaminergic pathway thereby causing 
antinociceptive effect. 
 
 Ketamine inhibits reuptake of catacholamines into postganglionic 
sympathetic nerve endings. 
 
 It has antagonistic effect on muscarnic receptors. 
 
 Has mild local anaesthetic like properties by its interaction with 
voltage gated sodium channel. 
 
 Ketamine suppresses inflammatory response of neutrophils and 
improves blood supply .Cytokines inhibition may also contribute 
its analgesic effect. 
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MECHANISM OF ACTION – 
  CARDIOVASCULAR EFFECT 
 Direct stimulation of CNS leads to increased sympathetic 
outflow thereby increasing cardiac output. 
 Depressed baroreceptor reflex secondary to Ketamine leads to 
enhanced sympathetic outflow. 
 Inhibition of reuptake of catecholamines. 
 
PHARMACOKINETICS 
 
It has rapid onset of action, short duration of action and high lipid 
solubility. Its pKa is 7.5. After administration, the Peak concentrations 
are attained after IV and IM injections at 1 minute and 5 minutes 
respectively. 
 It is not significantly bound to plasma proteins, crosses blood brain 
barrier, with as much as four to five times higher concentration seen in 
brain when compared to plasma. . It has high hepatic clearance (1 l/min), 
large volume of distribution (3 l/kg)and elimination half-life of 2 to 3 
hours. 
 
24 
 
METABOLISM 
 
Ketamine is demethylated by hepatic cytochrome p-450 into nor-
Ketamine. Nor-Ketamine has one-fifth to one third of activity of 
Ketamine and can be responsible for prolonged effects of Ketamine 
especially when it is given in repeated doses or as infusions. Nor-
Ketamine is then hydroxylated and conjugated and excreted by kidneys. 
Tolerance develops to Ketamine as it enhances its own metabolism. 
 
CLINICAL USES 
 
 ANALGESIA:  
 Subanaesthetic doses (0.2 mg/kg to 0.5 mg/kg IV) can produce 
intense analgesia. It is more for somatic pain than for visceral 
pain.  
 The site of action appears to be the thalamus and limbic system 
which interpret pain.  
 It can be useful adjuvant to opioids in low doses. Pain is also 
modulated by its action onopioid and NMDA receptors in spinal 
cord. 
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 INDUCTION OF ANAESTHESIA: 
 
 IV dose is 1-2 mg/kg and IM dose is 4-8 mg/kg. 
  Consciousness is usually lost in 30 to 60 seconds after IV and 2 
to 4 minutes after IM administration.  
 Normal airway reflexes are maintained even when patient 
becomes unconscious. 
 Return of consciousness takes place within 10-20 minutes but 
proper orientation occurs only after 60-90 minutes. 
  Amnesia persists for another 60-90 minutes. No retrograde 
amnesia is seen. 
 IM induction is used in children and mentally retarded patients 
because of its rapid onset of action. 
 Burns dressings, debridement, and skin grafting can be done 
using Ketamine as it has excellent analgesic properties and 
maintains airway which may be important in the presence of 
scar contractures and difficult airways. 
  Tolerance may be noted on repeated usage. 
 
 Induction in hypovolemic patients can be done because of its 
effects on sympathetic nervous system and its ability to 
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maintain blood pressure. Butit has to be used cautiously in a 
patient with heart disease as it can precipitate ischemia. 
 Patients with bronchial asthma are benefited because of its 
bronchodilatory effects. 
 It can be used in patients with malignant hyperthermia, but 
should be used with caution in patients with raised ICT, 
systemic or pulmonary hypertension and in acute intermittent 
porphyria. 
 
 OTHER USES 
 
 The neuraxial use is of limited value.5-50 mg in 3 ml saline 
intrathecally   produces variable and brief analgesia. 
 Ketamine is used to reverse tolerance to opioid analgesics due 
to its antagonism of NMDA receptors. 
 It can be used in restless leg syndrome and mental depression. 
 In subanaesthetic doses it can be used for bronchospasm. 
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SIDE EFFECTs 
 CENTRAL NERVOUS SYSTEM: 
 Intracranial pressure is said to be raised in patients due to 
increase in cerebral blood flow by as much as 60% in the 
presence of normocapnia. 
 But recent studies suggest that Ketamine can be 
administered in anesthetised mechanically ventilated 
patients with mild elevation of ICT without adversely 
affecting the cerebral perfusion. 
 Thiopentone, benzodiazepines administered before 
Ketamine reduces the raise in ICT. 
 CARDIOVASCULAR SYSTEM : 
 It resembles the stimulation of sympathetic nervous system. 
It causes increase in systemic and pulmonary blood pressure, 
increase in heart rate and myocardial oxygen demand. 
  There is increase in heart rate and systolic blood pressure 
for 3- 5 minutes after giving Ketamine which returns to basal 
levels only after 10-20 minutes. These hemodynamic 
alterations can be blunted with administration of 
benzodiazepenes or use of inhaledanaesthetics. 
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 VENTILATION AND AIRWAY : 
 Salivary and bronchial secretions can be increased if 
antisialogogue is not used along with Ketamine. 
  When used along with opioid medication it can cause 
respiratory depression. 
 
 EMERGENCE DELIRIUM 
 Visual, auditory, tactile, proprioceptive and confusional 
illusion can occur with the administration of Ketamine 
during emergence from anaesthesia. 
  This can progress to frank delirium. 
 Transient cortical blindness may occur occasionally. 
Hallucinations and dreams can be there up to 24 hours. They 
have vivid colours and vivid content. 
 
 
MECHANISM: 
 Depression of inferior colliculus and medial geniculate 
nucleus leads to misinterpretation of auditory and visual 
stimulus.  
 Loss of skin and musculoskeletal sensations, with decreased 
ability to perceive gravity, further increases this sensation. 
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INCIDENCE: 
 
 Incidence is 5-30%.  
 Predisposing factors are – age >15 years, female sex, dose > 
2mg/kg, history of similar problems and use of atropine or 
droperidol as premedication.  
 Its incidence decreases when it is repeatedly used. 
 
PREVENTION:  
 
 Benzodiazepines, inhaled anaesthetics and thiopentone 
decrease the incidence of delirium. 
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REVIEW OF LITERATURE 
 
1.PelinTrajeTopcuoglu, MD et al
5
  (Can J Anesth/J Can Anesth (2010) 
57:113–119) investigated the effect of Ketamine and priming on the 
intubating conditions and the onset time of propofol- Rocuronium 
induction.  
 
It was prospective, randomized double blind study with 120 ASA- I and 
II patients divided into 4 groups Ketamine, Ketamine-priming, priming 
and control. Ketamine at the dose of 0.5 mg/ kg or saline was given 
before induction or priming. 
 
 Priming was done with Rocuronium at the dose of 0.06 mg/kg 2 minutes 
before induction. This was done in priming group and Ketamine-priming 
group and saline was given in other two groups. No premedication was 
given as it was thought to influence the intubating conditions. Induction 
was done with propofol 2.5 mg/kg. Intubation was done after 1 minute. 
 
 They graded the intubating conditions according to the criteria 
established by Fuchs-Buder et al. The onset time of the neuromuscular 
blockade was noted at the disappearance of the last twitch in the TOF 
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monitor. They found that the time to reach TOF count of zero was 
significantly shorter with Ketamine ( p =0.001) and not by priming 
(p=0.94).the onset time was216 ± 20 s inthe control group, 212 ± 27 s in 
the priming group,162 ± 18 s in the Ketamine group, and 168 ± 22 s in 
the Ketamine-priming group. The intubating conditions was improved 
with Ketamine (p=0.001) and not by priming (p =0.34). 
 
Hence they concluded that small doses of Ketamine and not priming 
improved the intubating conditions and shortened the onset time of the 
neuromuscular blockade of Rocuronium.  
  
2.Youngmi Kang, et al,
6 
 studied effect of various dose of Ketamine on the onset time and 
intubating conditions of Rocuronium. 99 patients undergoing elective 
surgery were randomly allocated into 3 groups – control, K- 25, and    K - 
50. 
It was a prospective randomized single blind study. Control group 
received 1 ml of normal saline while K 25 group received 0.25 mg/kg of 
Ketamine; K 50 received 0.50 mg/kg of Ketamine before induction. 
Intubation was attempted after one minute of induction, condition being 
noted as excellent, good or poor depending on the vocal cord position, 
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reaction to tracheal intubation and ease of laryngoscopy. The onset time 
of neuromuscular blockade was noted from time of administration of 
Rocuronium to zero twitch by TOF stimulation. 
Onset time of Rocuronium in control group was 201 ± 103 sec, 136 ± 48 
sec in the group K 25, 139 ± 36 sec in the group K 50. Ketamine 
shortened the onset with a P value of< 0.05. 
There was no difference between groups K 25 and K 50.Intubating 
condition showed significant difference between the group C and group K 
25 (P < 005) and group K 50 (P < 0.05). Again no significant difference 
was seen in between groups K 25 and K 50. 
Hence they concluded that low dose Ketamine improved the intubating 
condition and the onset time of propofol Rocuronium anaesthesia. The 
dosing of Ketamine did not seem to affect the outcome. 
 
3. Byung-RyangAhn et al
7  
( Korean J Anesthesiol 2012 October 63(4): 
308-313)  investigated the effect of Ketamine and priming on the onset 
time of cis-atracurium in prospective double blind study. 
 
120 patients undergoing general anaesthesia were divided into four 
groups – Ketamine, Ketamine-priming, priming and control. Patients in 
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priming group got cis atracurium at the dose of 0.01mg/kg IV and 
Ketamine group got Ketamine 0.5mg/kg IV.  
The onset time was best for Ketamine-priming group (76.4 ±8 seconds) 
which was highly significant with p value of < 0.008.  The onset was also 
accelerated in Ketamine and priming group when compared to control. 
The intubating conditions were excellent in Ketamine-priming group 
(p<0.008) when compared to other groups. It was better in Ketamine and 
priming group when compared to control.No difference was found 
between Ketamine and priming group. 
 
Hence they concluded that Ketamine and priming can improve the 
intubating conditions. When used together they further improve these 
conditions and the onset time. 
 
4 Ledowski T et al
8
( Eur J Anaesthesiol. 2001 Aug;18(8):519-23), 
 
 They compared the effects of Fentanyl and s-Ketamine on the intubating 
conditions of Rocuronium.  90 patients who underwent elective surgery 
were studied. It was a prospective randomized double blind study. They 
were divided into three groups – control, Fentanyl (Fentanyl at the dose 
of 1.5 mcg/kg) and s-Ketamine(s-Ketamine the dose of 0.5 mg/kg). 
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They were induced with etomidate 0.3 mg/kg and Rocuronium 0.6 
mg/kg. They were intubated at the end of 60 seconds and intubating 
conditions were noted as excellent, good or poor. 
 
The intubating conditions in the Ketamine group was significantly better 
than control and Fentanyl group (p <0.001).The heart rate and arterial 
blood pressure significantly rose in the Ketamine group compared to 
Fentanyl and control group (p<0.001). 
 
The conclusion at the end of study was that s-Ketamine given before 
induction with etomidate and Rocuronium produced good intubating 
condition for RSI and can be used in the place of suxamethonium when it 
is contraindicated. 
 
5.Leykin Y, et al.
9
,.( Anaesth Intensive Care. 2005 Aug;33(4):462-8) 
 
They studied the effect of priming and induction agent on the intubating 
conditions of Rocuronium. 60 ASA I-II patients undergoing elective 
surgery cases were studied. It was a prospective randomized study with 
four groups –control-Ketamine, priming-Ketamine, control-thiopentone, 
and priming-thiopentone.  
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Priming was done with 0.04mg/kg of Rocuronium 3 minutes before 
induction. Induction was with either thiopentone (4mg/kg) or Ketamine(1 
mg/kg). Intubation was done 60 seconds after administration of 
Rocuronium. The intubating conditions were graded as excellent, good, 
fair or impossible to intubate. The onset of neuromuscular blockade was 
assessed with acceleromyography of the thumb. 
 
The proportion of cases with good intubating conditions was significantly 
higher when Ketamine was used as induction agent (p<0.05). Further, the 
ratio of good to excellent conditions of intubation was better with the use 
of priming dose (p<0.05). There was no difference between the onset 
time and hemodynamic changes in these groups. 
 
6.Anis S. Baraka, MD, et al
10
(AnesthAnalg 1997;84:1104-7) 
 
 compared the effects of thiopentone and Ketamine on intubating 
conditions when used along with Rocuronium as induction agents in 
partiuents. 
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40 full term pregnant patients undergoing elective LSCS were included. It 
was a prospective randomized double blind study. They were divided into 
two groups of twenty each. 
 
 Premedication was done with 0.5 mg of atropine intramuscularly 30 
minutes prior to induction. Opioids were given only after delivery of the 
baby. One group was induced with thiopentone 4 mg/kg and the other 
with Ketamine 1.5 mg/kg. Muscle relaxation was with Rocuronium at the 
dose of 0.6 mg /kg. 
 
 The time taken from the injection of Rocuronium to T1/control ratio of 
50 % blockade, time taken for maximum blockade (onset time), and time 
taken for T1 to reach 25 % of control value (recovery time) were noted 
for each group. Tracheal intubation was attempted at 50 % neuromuscular 
blockade and the intubating conditions were graded according to 
Cooper’s criteria. Time taken for 50% neuromuscular blockade, onset 
time, and recovery time and intubation condition were compared between 
the groups. 
 
The time to reach 50 % blockade, the onset time (105 ± 35 s in the 
thiopentone group and 101 ± 35 sin the Ketamine group) and recovery 
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time were not statistically significant between the groups. However, the 
intubating conditions were excellent or good in all 20 cases in Ketamine 
group compared to 5 in thiopentone group and it was found to be 
significant. 
The conclusion of the study was that KetamineRocuronium can be used 
for RSI in LSCS where suxamethonium is contraindicated. 
 
7 .P. Hans,  et al
11
 (Anaesthesia, 1999, 54, pages 266–296) 
 
They compared the effects of thiopentone and Ketamine, as induction 
agents, on the intubating conditions while using Rocuronium for rapid 
sequence induction. 32 ASA I patients undergoing elective surgery were 
divided into two groups and effect of Ketamine and thiopentone was 
studied.  
 
All patients received Alprazolam 1 mg orally one hour before surgery and 
2mg midazolam was given 2 minutes before induction. Induction was 
done with thiopentone 5 mg/kg or Ketamine 2.5mg/kg followed by 
Rocuronium 0.6 mg/kg for muscle relaxation. Tracheal intubation was 
done after 60 seconds and intubating conditions were noted. The degree 
of neuromuscular block was assessed at the time of intubation as the 
percentage decrease in the height of T1 in TOF monitor.  
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The intubating conditions in Ketamine group was significantly better 
when compared to the thiopentone group (p=0.002). Vocal cord position 
and diaphragmatic movements were found to be better in patients in 
Ketamine group (p=0.002). The grade of neuromuscular blockade at the 
time of intubation did not differ much between the groups.   
 
The study concluded that the intubation condition was better with 
Ketamine when compared to thiopentone.   
 
7.WorawutLapisatepun, et al.
12
(Chiang Mai Med J 2010;49(1):11-17.) 
 
ina  prospective double blind study compared the  intubating 
conditionsbetween Ketamine and propofol induction.  80 ASA I –II 
patients undergoing elective surgery were studied.  
 
Patients were divided into two groups to receive propofol 2.5mg/kg 
(group P) or Ketamine 2.5mg/kg (group K) followed by Rocuronium 0.45 
mg/kg. Patients were not premedicated. After induction with agents as per 
their group, they were intubated at 75 seconds.  
 
The intubating conditions were assessed using criteria devised by cooper 
et al., as excellent, good, fair or poor. The time taken for 100% 
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suppression of single muscle twitch was noted along with twitch height at 
75 seconds. Hemodynamic changes were also noted for comparison. 
 
All patients were intubated in the first attempt. The onset time of 
neuromuscular block was 71 seconds and 62.5 seconds in group K and P 
respectively, the difference was not statistically significant (p=0.46). The 
intubating conditions found to be acceptable was 90 % in group K and 85 
% in group P, again not statistically significant (p=0.5). Hemodynamic 
comparisons showed that group K had significant rise in MAP (p=0.00) 
after induction, group P had significantly higher heart rate (p= 0.040) 
after induction. 
 
Hence they concluded that Ketamine or propofol could be used for rapid 
sequence induction with good intubating conditions at 75 seconds after 
induction. Even though they expected Ketamine to produce better 
intubating conditions because of its better analgesic and sedative effects, 
they could not prove any statistical significance. The choice of the drugs 
was mainly for its hemodynamic effects. 
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9.Demet DOGAN EROL and CemilKAYA
13
 ,(EROL et al. Gynecol 
Obstetric 2012, 2:1,doi:10.4172/2161-0932.1000110) 
 
They evaluated retrospectively the intubating conditions in 86 patients 
who received Rocuronium for muscle relaxation with propofol Ketamine 
induction. They concluded that even 0.4 mg/kg of Rocuronium with 
Ketamine at the dose of 1 mg/kg can produce good intubating conditions 
at 30 seconds. 
 
10. Ji Young Kim et al14(J AnesthDOI 10.1007/s00540-012-1485-4) 
 
Studied the effect of alfentanil versus Ketamine on the hemodynamics 
and intubating conditions of Rocuronium bromide in children.  54 
children aged between 3-9 years undergoing tonsillectomy were divided 
into 2 groups, alfentanil group (alfentanil 20 mcg/kg) and Ketamine 
group (Ketamine 0.5mg/kg ). All patients were induced after one minute 
of giving the test drug with propofol 2.5 mg/kg and Rocuronium 0.3 
mg/kg and anaesthesia was maintained with propofol. Intubation was 
done at 2 minutes.  
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The ratio of TOF compared to the basal reading was noted at 2 minutes.  
The parameters compared were neuromuscular blockade, intubating 
conditions and hemodynamic alterations.  
 
The intubation condition and the twitch height at 2 minutes were not 
significantly different between the groups. The MAP arterial pressure was 
significantly higher after intubation in Ketamine group. They concluded 
that both Ketamine and alfentanil produce good intubating conditions 
with Rocuronium at the dose of 0.3 mg in children. 
 
 
11 T. Ezri, .Szmuk R. D. et al
15 
(Acta Anaesthesiologica Scandinavica 
Volume 47, Issue 9, pages 1067–1072, October 2003) studied the effect 
of alteration in cardiac output on the onset time of Rocuronium. They 
used noninvasive cardiac output monitor to find out the effect of Esmolol 
and Ephedrine. 
 
The result was that the onset was faster with Ephedrine(52.2 ± 16.5 s) and 
longer after Esmolol (114.3 ± 11.1 s) as compared to Placebo 
(87.4 ± 7.3 s) (P < 0.0001).Cardiac output was significantly increased 
(P < 0.05) withEphedrine for 15 min after Rocuronium. With Esmolol, 
Cardiac Output decreased (P < 0.05) at 3 and 6 min.  
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Hence the conclusion was that by altering the cardiac output Ephedrine or 
Esmolol could affect the onset time of Rocuronium. 
 
12.PeterSzmuk, MD, et al
16
(AnesthAnalg 2000;90:1217–9) 
 
They Hypothesized that Esmolol because of its decrease in cardiac output 
will prolong the onset of Rocuronium while Ephedrine will shorten its 
onset. The effect of Ephedrine and Esmolol on onset time of Rocuronium 
was studied.  
 
The onset time of Rocuronium in placebo group was 93± 6 seconds,in 
Ephedrine group 66±46.6 seconds and in Esmolol group was 118.6± 
11seconds.The onset time ofRocuronium was significantly shorter after 
Ephedrine (22%) and longer after Esmolol (26%), as compared 
toPlacebo.  
 
They did not find any significant difference among the groups with 
respect to heart rate and hemodynamics. Hence they concluded that 
Esmolol prolongs the onset time of Rocuronium. 
 
 
 
43 
 
13 .D. W. Han, et al
17
(Anaesthesia, 2008, 63, pages 856–860) 
 
In their study, the effect of timing of administration of Ephedrine on the 
onset time of Rocuronium was noted. The administration of Rocuronium 
was donearound 4 minutes which coincides with the peak action of 
Ephedrineon the cardiac output. 
 
 They found out that onset of Rocuronium was shortened when given 
early (4 minutes before Rocuronium) by 20% (p=0.032) compared to late 
(30 seconds before Rocuronium) and control group. There was no 
difference in intubating conditions or duration of action. 
 
They concluded that Ephedrine given 4 minutes before Rocuronium can 
be used in situations where suxamethonium is contraindicated and rapid 
intubation is required. 
 
 
14.M. D. Gopalakrishna, et al
18
{British Journal of Anaesthesia 99 (2): 
191–4 (2007) } 
The effect of various doses of Ephedrine was compared with respect to 
the onset time of Rocuronium. They concluded that Ephedrine at the 
doses of 75 mcg /kg (p=0.003) to 100 mcg/kg (p=0.001) improved the 
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intubating conditions of Rocuronium without affecting the 
hemodynamics. Even though the onset time of neuromuscular blockade 
was faster with the administration of Ephedrine, it was not statistically 
significant. 
 
15.Hernan R. Munoz, MD, et al
19
 (AnesthAnalg 1997;85:437-40 437) 
 
Effect of Ephedrine on the onset time of Rocuronium was studied. 
Ephedrine reduced the onset time to 72± 18seconds.When compared, it 
was to 92±31 seconds in placebo group(p=0.0006). Hence they concluded 
that Ephedrine reduces the onset time without adversely affecting the 
hemodynamics in healthy subjects. 
 
16C. H. Tan, et al, 
20 
 
 
concluded that Ephedrine in combination with propofol produced good 
intubating condition with Rocuronium than propofol alone in their study ( 
Anaesthesia, 2002, 57, pages 223-226). 
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17.YoungJu Won et al
21
(Korean J Anesthesiol 2010 October 59(4): 244-
248) 
 
They Hypothesized that administration of phenylephrine will prolong the 
onset of action of Rocuronium. 64 patients undergoing elective surgery 
were divided into two groups- phenylephrine (0.9 mcg/kg) or saline. 
 
Test drug was given five minutes before induction. The effect of the test 
drug on the onset of Rocuronium was compared. The onset time was 
delayed with phenylephrine. There was no difference between the groups 
with respect to heart rate, arterial blood pressure and intubating 
conditions. 
 
18 .Anis Baraka MD, et al
22
( CAN J ANAESTH 1992 / 39:2 / pp 135-8) 
 
The effect of increase in cardiac output in pregnancy on onset time of 
neuromuscular blockade of vecuronium was studied. The onset time (that 
is, 50% neuromuscular blockade) was earlier in pregnant  patients(80 ± 
30 sec)than in the control group (144 ± 43 sec).the intubating conditions 
were adequate.  
They concluded that the administration of vecuronium as per body weight 
produced rapid onset of neuromuscular blockade in pregnant woman. 
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19.GerardAudibert, MD et al
23
(AnesthAnalg 1996;82:848-53) 
 
In their study, they compared the onset time of mivacurium, vecuronium 
and Rocuroniumin an arm with reduced circulation caused by 
insufflations of a tourniquet.The onset time of maximal blockade of 
Rocuronium in the arm with tourniquet was half that of the perfused arm. 
This proved that the onset time of Rocuronium depended mainly on 
circulatory factors and not much on non-circulatory factors. 
 
20Yong-guang Wanget al
23
(J Pharm PharmaceutSci 10 (1): 53-60, 
2007) 
 
They studied the effect of hyperthyroidism on the onset time of 
Rocuronium.Eighteen hyperthyroid patients undergoing subtotal 
thyroidectomy were compared with eighteen euthyroid patients 
undergoing subtotal thyroidectomy.  
 
They were induced with midazolam, Fentanyl and propofol. Rocuronium 
at the dose of 0.6 mg/kg was used for intubation and onset time 
compared. The onset time in hyperthyroid group was significantly shorter 
at 56± 10 seconds compared to 76 ± 13 seconds in euthyroid 
group(P<0.05) 
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They concluded that the onset time was significantly shorter in 
hyperthyroid patient. 
 
21 Z. Begecet al
24
(Anaesthesia, 2009, 64, pages 282–286) 
 
 compared the effects of Ketamine and Fentanyl on the insertion 
conditions of proseal LMA. they Concluded that the hemodynamics was 
not altered with administration of 0.5 mg/kg of Ketaminebefore 
induction,. No difference in insertion conditions were noted between the 
groups. 
 
22 Ittichaikulthol W et al 
25 
(J Med Assoc Thai. 2004 Mar;87(3):264-9). 
 
In their study concluded that Ephedrine significantly shortened the onset 
time of Rocuronium (p<0.001) and can be used for Rapid Sequence 
Induction. 
 
23 Santiveri X et al
26
(Rev EspAnestesiolReanim. 2003 Apr;50(4):176-
81) 
 
concluded that premedication with Ephedrine reduces the onset time of 
Rocuronium and not that of  atracurium. 
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MATERIALS AND METHODS 
 
It was a randomized single blinded study conducted in Institute Of 
Anesthesiology And Critical Care, Madras Medical College, Chennai. 
After getting institutional ethical committee clearance and informed 
consent,  80 patients fulfilling the inclusion criteria were selected. 
 
INCLUSION CRITERIA 
 
• Age         :18 – 60 years 
• ASA         : I & II 
• Surgery  : Elective  surgery 
• Who have given valid informed consent 
 
EXCLUSION CRITERIA 
 
• Not satisfying inclusion criteria. 
• Patients with anticipated difficult intubation 
• Increased risk of regurgitation 
• History of cardiorespiratory illness 
• Neuromuscular disorders 
• Hepatic disease 
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• Renal disease 
• known sensitivity to the drugs  
• Pregnant females 
• Emergency surgery 
 
MATERIALS: 
 
• Laryngoscopes of various sizes,bougie,oropharyngeal airway 
• Drugs – 
propofol, Ketamine ,Rocuronium ,Fentanyl, glycopyrrolate, 
xylocard, normal saline, Ephedrine ,atropine, 
succinylcholine, midazolam,sevoflurane and other 
emergency drugs. 
• Monitors –  
ECG, NIBP, SPO2, EtCO2, neuromuscular monitor 
(INMED nerve locator and peripheral nerve stimulator), 
• 2 cc,5 cc and 10 cc syringe 
• 18G intravenous cannula. 
• Appropriate size endotracheal tubes 
• Weighing machine 
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PARAMETERS NOTED WERE: 
 
A. ONSET  TIME 
 
After induction, the ulnar nerve of the patient was stimulated 
and supramaximal stimulus was noted. The time taken 
between administration of Rocuronium and TOF count of zero 
was taken as onset time. 
 
 
B. INTUBATION CONDITIONS 
 
Intubation was done at 60 seconds and the intubation 
conditions were noted according to criteria established by 
cooper et al. The score is graded as excellent, good, fair or 
poor with respect to jaw relaxation, vocal cord position and 
diaphragmatic movements.  If the vocal cord was adducted 
then the attempt was abandoned and another attempt made 
after 60 seconds. 
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GRADING OF INTUBAING CONDITIONS BY COOPER, ET AL 
 
 
SCORE 
JAW 
RELAXATION 
VOCAL 
CORDS 
RESPONSE TO 
INTUBATION 
0 POOR CLOSED 
SEVERE 
COUGHING/ 
BUCKING 
1 MINIMAL CLOSING MILD COUGHING 
2 MODERATE 
MOVING 
SLIGHTLY 
DIAPHRAGMATIC 
MOVEMENT 
3 GOOD OPEN NONE 
 
\The Cormack lehane grading and Percentage Of Glottic opening  
score were also noted. 
Cormack and lehanne grading was graded as : 
1. Visualization of entire vocal cords 
2. Visualization of posterior part of laryngeal aperture 
                       2a - Visualization of posterior part of vocal cords 
                       2b - Visualization of arytenoids only 
3.  Visualization of epiglottis 
                       3a – epiglottis liftable 
                       3b – epiglottis adherent or only tip visible 
4.  No glottis structures seen 
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C. The hemodynamic alterations in the form of systolic blood pressure, 
diastolic blood pressure and mean arterial blood pressure were noted at 
various stages  
 baseline,  
 at the time of administration of premedication, 
 at the time of administering  test drug, 
 after induction, 
 after intubation, 
 1minute,3minutes and 5minutes after intubation 
 
Heart rate variations during the same period were also noted for 
comparison. 
 
CONDUCTION OF THE STUDY 
 
After getting institutional ethical committee clearance, all patients posted 
for elective surgeries in general surgery and ENT theatres in our institute 
were chosen. Patients who had difficult airway and with other exclusion 
criteria were excluded. .After getting written informed consent, 80 
patients of age group 18 to 60 years with ASA I and II, who satisfied our 
inclusion criteria ,were selected and randomly allocated into 2 groups 
using closed envelope method.  
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After connecting basic monitors- ECG,NIBP,SpO2,temperature,baseline 
values were noted. Intravenous access was obtained with a 18 gauge 
venous cannula. All patients were given 10 ml/kg of normal saline before 
induction.  
 
Inj Glycopyrollate 5 mcg/kg, inj midazolam 1 mg, inj Fentanyl 2mcg/kg 
and inj ondansetron 4 mg iv  were given to all patients as premedication. 
All patients were preoxygenated with 100% Oxygen for 5 minutes. 
Two minutes before induction, Group I received5 ml of normal saline, 
and groupII received Ketamine 0.5 mg/kg. 
 
Induction was done using 2.5 mg/kg of propofol. As soon as the patient 
became unconscious, supramaximal stimulus was calibrated by 
stimulation of ulnar nerve and contraction of adductor pollicis muscle. 
TOF monitoring was done every 10 seconds.Inj Rocuronium at the dose 
of 0.6 mg/kg was administered.  
 
Once the patient became apneic ,the patient was ventilated with 100% 
oxygen at 6 liters per minute and sevoflurane of 2%.Laryngoscopy was 
done at 60
th
 second of muscle relaxant administration. Patients were 
intubated at 60
th
 second with appropriate size oral endotracheal tube and 
intubating conditions were noted as per the criteria established by Cooper 
et al. if vocal cords were adducted or the intubating conditions were poor, 
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intubation was abandoned. Patients were ventilated with 100 % oxygen 
and 2% sevoflurane for another minute .Reintubation was tried 60 
seconds later. 
 
 The heart rate,blood pressure and mean arterial pressure were recorded at 
the time of administering premedication and administration of test drug. 
Same parameters were noted after induction, after intubation, thereafter 
1,3 and 5 minutes following intubation. Cormack lehanne grading and 
percentage of glottis opening score was also noted. 
 
Intubating conditions was assessed as excellent, good, and poor using 
criteria established by cooper et el. 
 
The data collected was analyzed using statistical package for social 
sciences (SPSS version 15). All qualitative variables were compared 
using chi square test and quantitative variables using students’t’ test. 
 
It was calculated that 34 patients per group were required for a 0.05 level 
of significance and 80% power to detect at least a 50% difference 
between the control group and the other group with respect to acceptable 
intubating conditions. 
 
we chose a study with 40 patients in each group. 
 
55 
 
OBSERVATIONS AND RESULTS 
This was a prospective, randomized, single blinded study done to assess 
the effect of Ketamine on the onset time of Rocuronium. 
 
 The primary end point was the onset of neuromuscular blockade and the 
quality of intubation. Secondary measures done were the heart rate and 
hemodynamic changes that occurred during the course of intubation 
 
Statistical analysis was done using statistical package for social sciences 
(SPSS for windows, version 15). Results are represented here as mean 
and standard deviation. 
 
 All qualitative variants were compared using Chi Square test. 
Quantitative variants using students‘t’ test. A ‘p’ value of  less than 0.05 
was considered significant. 
 
80 patients were included in this study. Group A is SALINE group and 
Group B is Ketamine group.We were able to intubate all the patients in 
the first attempt. There demographic characters were all comparable 
between groups. 
\ 
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COMPARISON OF DEMOGRAPHIC PROFILE 
Table 1. Demographic profile: AGE(IN YEARS)  
 
 
Group 
 
Number 
 
Mean 
 
SD 
 
P value 
A 40 32.38 11.302 
0.866 
N.S 
B 40 31.95 11.161 
 
 
The mean age of patients in control group was 32.38 ±11.32 years and in 
Ketamine group was 31.95 ±11.16 years. Hence they are comparable with 
respect to age.  
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Table 2. Demographic profile: SEX: 
 
With regard to sex distribution between the groups, both were 
comparable and there was no statistical difference between the two 
groups (p=0.820)  
 
 
 
 
 
 
 
 
Group 
Male 
 
Female  
P value 
No % No % 
A 17 42.5 23 57.5 
820 
N.S 
B 16 40.0 24 60.0 
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COMPARISON OF BMI 
In our study we compared the weight and BMI of the patients in the two 
groups,as they can influence the intubating conditions. The height, weight 
and BMI were comparable between the groups and there was no 
statistically significant difference between the two groups. 
 
Table  3. DEMOGRAPHIC PROFILE: WEIGHT (IN KG) 
Group No Mean SD P value 
A 40 57.23 9.986 .216 
N.S B 40 54.80 7.183 
 
 
Table 4: Demographic profile: height (IN cm) 
Group No Mean SD P value 
A 40 160.28 9.378 
.094 
N.S 
B 40 159.88 8.275 
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Table  5. Demographic profile: BMI:( KG/ m
2
) 
 
Group No Mean SD P value 
A 40 21.391 1.8010 
.080 
N.S 
B 40 22.110 1.8190 
 
COMPARISON OF EASE OF INTUBATION 
Hemodynamic alterations of intubation not only depend on the degree of 
relaxation of the vocal cords but also on the anatomic variations that 
make the intubations easy or difficult. Thus we measured modified 
Mallampatti score,Cormack lehane grading and the Percentage OfGlottic 
opening as a measure of difficulty of intubation. 
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Table  6. Distribution of MMS grade: 
Group 
MMS I MMS II MMS III P value 
No % No % No % 
.280 
N.S 
A 19 47.5 19 47.5 2 5 
B 13 32.5 26 65 1 2.5 
 
 
 
MMS score was not significantly different between the two groups. The p 
value is 0.280. 
 
Table  7. Distribution  of POGO score: 
Group mean S D P value 
A 81.93 26.383 
0.258 
N.S 
B 87.88 19.855 
 
 
The Cormack lehane grading and POGO score did not differ significantly 
between the two groups. 
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Table 8. Distribution of CL  grade: 
Group 
I II A II B 
P value 
No % No % No % 
A 25 62.5 11 27.5 4 10 
922 
N.S 
B 26 65 11 22.5 3 2.5 
 
 
 
COMPARISON OF INTUBATING CONDITIONS 
Patients were intubated at 60 seconds and intubation conditions noted as 
per cooper’s criteria. We were able to intubate all the patients orally at 60 
seconds using appropriate size McIntosh blade and endotracheal tubes. 
Our finding were 
s 
 Excellent intubating conditions were seen in 22 patients in saline 
group and 25 patients in Ketamine group, 
 good intubating conditions were seen in 10 patients in saline group 
and 10 in Ketamine group,  
 While fair intubating conditions were seen in 8 patients and 5 
patients respectively.  
  Both the groups did not have any poor intubating condition  
62 
 
 
 
 
Table  9. Distribution of intubating conditions: 
 
Grade 
Group A Group B 
Number percentage number percentage 
excellent 22 55 25 62.5 
Good 10 25 10 25 
Fair 8 20 5 12.5 
 
 
 Table 10 :Acceptable intubating conditions 
 
Group 
excellent Good 
Acceptable 
Conditions P value 
No No No % 
A 22 10 32 80 0.642 
N.S B 25 10 35 87.5 
 
Excellent and good intubating conditions were taken acceptable. In 
Ketamine group it was 87.5% and in saline group it was 80%.Statistical 
analysis done of intubating conditions using chi-square test showed no 
statistically significant difference between the groups. The ‘p’ value was 
0.642. 
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Table  11. time required for onset of blockade: ( IN SECONDS) 
Group No Mean SD P value 
A 40 127.5 48.758 
.001 
Significant 
B 40 93.48 33.749 
 
 
 
 
The mean onset time of neuromuscular blockade was statistically 
significant in Ketamine group than with saline group. The mean duration 
with Ketamine group was 93.48± 33.74 seconds versus 127.50±48.75 
seconds in saline group. The ‘p’ value is 0.001 and it is statistically 
significant. 
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COMPARISON OF HEMODYNAMICS 
The hemodynamic alterations were noted and compare between the 
groups. There was no statistically significant difference in the systolic 
and diastolic blood pressure between the groups throughout the study 
period. 
Table 12 : comparison of  mean of systolic blood pressue (mm Hg) 
 
Group A Group B 
P value 
Mean S D Mean SD 
Basal 
123.30 15.061 119.03 13.766 0.189 
Premed 
122.25 13.272 115.95 11.489 0.26 
After test 
drug 121.95 13.142 120.28 12.677 0.563 
After 
induction 108.43 16.295 112.25 14.961 0.278 
After 
intubation 135.03 16.482 129.85 17.222 0.174 
1 minute 
126.65 18.524 125.03 16.247 0.678 
3 minutes 
120.18 14.970 118.98 16.285 0.732 
5 minutes 
120.13 13.758 
115.93 
15.669 0.207 
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Table 13 : comparison of  mean of  diastolic blood pressue (mm Hg) 
 
Group A Group B 
P value 
Mean S D Mean SD 
Basal 
77.55 8.327 74.65 6.475 0.189 
Premed 
76.38 6.736 73.28 6.801 0.26 
After test drug 
76.85 7.113 74.58 5.134 125.03 
After induction 70.25 11.038 71.72 9.902 0.278 
After intubation 
85.93 14.995 85.13 12.999 0.174 
1 minute 
82.55 10.085 
80.70 
16.128 0.678 
3 minutes 
77.22 9.112 74.80 10.821 0.732 
5 minutes 
75.35 10.187 
75.38 
10.280 0.207 
 
COMPARISON OF MAP OF 80 PATIENTS 
But, comparison of mean arterial blood pressures of the two groups 
showed that MAP was well maintained in the Ketamine group 
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Table  14. COMPARISON OF MAP OF 80 PATIENTS ( mm Hg ) 
 
 
Group 1 Group 2 
P value 
Mean SD mean SD 
Basal 92.80 8.43 89.44 7.493 0.064 
Premeded 91.67 7.62 87.50 6.688 0.011 
Test Drug 91.88 7.53 89.80 6.120 0.181 
Induction 82.98 11.87 85.23 10.69 0.374 
Intubation 102.29 13.98 100.03 13.42 0.463 
1 min 97.25 15.76 95.48 10.80 0.559 
3 min 91.54 10.89 89.53 10.45 0.401 
5 min 90.27 10.05 88.89 10.97 0.559 
 
The fall in mean arterial pressure in the Ketamine groupafter induction 
when compared to baseline was 4.2 mm hg. The fall in mean arterial 
pressure in saline group was 9.82 mm Hg. This was statistically 
significant at P=0.036. 
The mean arterial pressures at 5 minutes after intubation in both the 
groups were comparable. The change in mean arterial pressure from 
baseline at 5 minutes in both the groups did not differ significantly (p= 
0.444) 
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Table   15 Comparison of change in MAP from baseline MAP 
 ( mm Hg ) 
  
 Group I Group II P value 
Induction - 9.82 - 4.20 0.036 
5 minutes - 2.52 - 0.55 0.444 
 
HEART RATE VARIATIONS 
 
Heart rate was noted between the two groups throughout the study and 
compared .it was comparable between the groups in this period at all 
times. 
Table  16. COMPARISON OF HEART RATE OF 80 PATIENTS  ( mm Hg ) 
Group No 
BASELINE INDUCTION 5 MIN 
Mean SD Mean SD MEAN SD 
A 40 82.43 10.49 87.53 14.05 90.27 10.05 
B 40 84.98 8.65 91.05 11.99 86.50 11.42 
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DISCUSSION 
 
In our study, we found that addition of Ketamine at the dose of 0.5 mg/kg 
given before induction shortened the onset of Rocuronium 0.6 mg/kg. 
Even though the intubating condition was acceptable and the percentage 
of excellent intubating conditions was around 62.5 % with Ketamine, we 
could not find any statistical difference with the control group. 
 
Rapid sequence induction requires use of agents which have shortest 
onset of action thereby limiting hypoxia and chance of aspiration. 
Suxamethonium has traditionally been used for rapid sequence induction. 
When suxamethonium is contraindicated, Rocuronium is the next choice. 
But at doses of 0.9-1.2 mg/dl , the duration of action is prolonged.   
 
To overcome this various strategies have been used to reduce the onset 
time and improve the intubating conditions while using a lower dose of 
0.6 mg/dl.  One such method is to maintain the cardiac output during 
induction. Gerard Audibert, MD, et al
23
 concluded in their study that 
for low potency drugs like Rocuronium the onset depends more on 
maintaining circulation to the muscle and not on local factors. 
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Study conducted by Yong-guangWangetal
29
 in hyperthyroid patients in 
whom cardiac output is increased also gives credence to the use of this 
strategy. They found that onset time in hyperthyroid patients is shorter 
when compared to that of euthyroid patients. 
 
In our study, we used Ketamine at a low dose of 0.5 mg/kg to increase the 
sympathetic outflow. This will blunt the fall of blood pressure caused by 
propofol and maintain the cardiac output. Also ,by raising the 
catecholamine levels, it will enhance the blood flow to muscleby 
increasing the beta2 activity.Hence its action is twofold. 
 
In our study, we found that the onset time was significantly shortened 
with the use of Ketamine. The onset time in Ketamine group was 93.48± 
33.74 seconds versus 127.50±48.75 seconds in saline group. The ‘p’ 
value is 0.001.  
 
These findings were similar to that of PelinTrajeTopcuoglu, et al.
5
the 
onset time was significantly shorter with Ketamine( p =0.001) not by 
priming (p=0.94).216 ± 20 s inthe control group, 212 ± 27 s in the 
priming group,162 ± 18 s in the Ketamine group, and 168 ± 22 s in the 
Ketamine-priming group. 
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 We found that the onset time was shorter in both groups than their study. 
The reason could be that we used Fentanyl and sevoflurane at the time of 
induction. Several studies suggest that sevoflurane can shorten the onset 
of  Rocuronium.
30,32 
 
Youngmi Kang, M.A.,etal
6
findings also concur with ours. They did not 
use any opioids or volatile anaesthetics before intubation.Onset time of 
Rocuronium in control group was 201 ± 103 sec, 136 ± 48 sec in the 
group K 25, 139 ± 36 sec in the group K 50.the onset time was 
significantly shortened with p value of < 0.05. 
 
Byung-RyangAhnet al
7
compared Ketamine and priming on the onset 
time of cis-atracurium. Their study also correlates with our study. The 
onset time was best with Ketamine – priming group (76.4 ±8 seconds) 
which was highly significant with p value of < 0.008.Ketamine or 
priming alone also reduced the onset time of cis-atracurium when 
compared to control group. 
 
Leykin Y, et al.,9could not demonstrate any difference between the 
thiopentone group and the Ketamine group with regard to the onset time. 
They used a total dose of 0.4 mg/kg of Rocuronium, which is around one 
ED95. Since the onset depends upon the number of molecules at 
neuromuscular junction especially for low potency drugs like 
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Rocuronium.
1,2
 The use of twice ED95 (0.6 mg/kg) might have decreased 
the onset time. 
 
Anis S. Barakaet al
10
 also differed from our study. They compared the 
effects of induction agents in pregnant ladies on the onset time of 
Rocuronium. They could not find any significance between the 
thiopentone and Ketamine groups. The time taken from the injection of 
Rocuronium to T1/control ratio of 50 % blockade and time taken for 
maximum blockade (onset time) was not different. Since pregnant 
patients already have increased cardiac output as their altered physiology 
it is possible that addition of Ketamine did not alter the onset time.
22 
 
Similar to Ketamine, Ephedrine an indirect acting sympathomimetic will 
increase the cardiac output and is expected to reduce the onset time. 
Esmolol a beta blocker similarly due to its effect on cardiac output will 
prolong its onset time. 
 
T. Ezri, .Szmuk
*
, R. D. et al
15
compared the effect of Esmolol and 
Ephedrine on the onset time of Rocuronium, they found that Ephedrine 
reduced the onset time (P < 0.0001), and Esmolol prolonged the onset 
time (P < 0.05). They monitored the cardiac output and found it to be 
significantly increased in Ephedrine and decreased with Esmolol. This 
corresponded with their clinical finding. 
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C. H. Tan, et al,
20
Hernan R. Munoz, et al,
19
Gopalakrishna, et al,
18
D. 
W. Han, et al,
17
 and Peter Szmuk, et al
16
  also published similar results. 
 
 
Young Ju Wonet al
21
studied the effect of phenylephrine on the onset 
time of Rocuronium. Phenylephrine though maintains the mean arterial 
pressure by increasing the peripheral vascular resistance, it does not alter 
the cardiac output or the blood supply to the muscles. Thus it is not 
expected to shorten the onset. In fact, in their study the onset time was 
delayed compared to saline. 
 
 
Ketamine has anesthetic properties.
1,2,5
 By providing analgesia and 
hypnosis, airway reflexes are obtunded and hence, it can improve the 
intubating conditions.  Thus we hypothesized that Ketamine not only 
shortens the onset but also provides better intubating conditions. 
 
 In our study, we were able to intubate all the patients in first attempt. 
Acceptable intubation conditions were found in 87.5 % of patients in 
Ketamine group versus 80 % of patients in saline group. We could not 
demonstrate a significant difference between the two groups, (p=0.641).. 
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WorawutLapisatepun, et al
12
results were similar to ours. The 
percentage of acceptable intubating conditions was 90% in Ketamine 
group compared to 85% acceptable intubating conditions in propofol 
group. They could not demonstrate a significant difference between the 
two groups (P =0.499) 
 
Ji Young Kim et al
14
study also concurs with our study. They compared 
low dose Ketamine and alfentanil on the intubating conditions of 
Rocuronium. The percentage of acceptable intubating conditions and the 
mean twitch height at the time of intubation was similar between the two 
groups and no significant  difference could be found between the groups 
(p=0.326). 
 
Z. Begecet al
24
compared the effect of alfentanil and low dose Ketamine 
on insertion conditions for proseal LMA. They could not demonstrate any 
statistical difference between the insertion conditions. 
 
Results of the study done byPelinTrajeTopcuoglu, et al
5
differ from our 
study. The intubating conditions were acceptable in 96.6% of cases in 
Ketamine group and 90% of cases in Ketamine –priming group , which is 
similar to our findings.  
 
But in the control group, the percentage of acceptable intubating 
conditions was 53.3% and in the priming group it was 66.6%.Hence they 
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concluded that intubating conditions were better with Ketamine and not 
priming. This differs from our findings.The reason could be that we used 
Fentanyl as premedication and sevoflurane before intubation in our study 
which could have affected both the groups in providing better intubating 
conditions. 
 
Byung-RyangAhnetal
7
also used low dose Ketamine and priming to 
improve the intubating conditions of cis-atracurium .they concluded that 
both Ketamine and priming improved the intubating conditions. 
 
Leykin Y, et al
9
study concluded that Ketamine improved the intubating 
conditions when compared to Fentanyl or priming. Their result differed 
from that of our study. The reason for such a difference could be that they 
used a higher dose of Ketamine (1mg/kg ).  
 
Hemodynamic alterations between the groups were also compared in our 
study. The rapid distribution of the drug to the neuromuscular junction 
was due to the maintenance of hemodynamics of Ketamine.   
 
In our study, there was fall in mean arterial  pressure after induction in 
both the groups. The fall was less (-3.12 mm Hg) and mean arterial 
pressure was better maintained in Ketamine group compared to saline 
group (-9.82 mmHg) with a p value of 0.036. 
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 The heart rate were also comparable throughout the study period and did 
not achieve level of statistical significance 
 
PelinTrajeTopcuogluetal
5
concur with our study.The decrease in mean 
arterial blood pressure in Ketamine group was significantly less in 
Ketamine groups when compared to others (p=0.001). 
The heart rate was comparable between the Ketamine and non-Ketamine 
groups without any statistical significance (p=0.095) . 
 
Even though the mean blood pressures and heart rates were higher in 
Ketamine groups compared to non-Ketamine groups, Byung-
RyangAhnet al
7
could not demonstrate any significant difference 
between these two groups. 
 
Ledowski T et al
8
found that the heart rate and arterial blood pressures 
rose significantly in Ketamine group when compared to Fentanyl 
(p<0.001) 
 
Leykin Y, et al
9
did not find any significant differences in hemodynamics 
between the Ketamine and thiopentone groups. 
P. Hans et al
11
in their study, report that there was 11% raise in systolic 
blood pressure (p=0.0006) and 10% mean aterial pressure in Ketamine 
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group when compared to thiopentone group  just before intubation when 
compared to the to the baseline values. 
 Such a raise in blood pressure could be due to the large dose of Ketamine 
(2.5 mg/kg) used in this study .the heart rate changes were not significant 
between the groups. 
 
Worawut Lapisatepun, et al
12
also reported similar findings. As they 
also used higher dose of Ketamine (2.5 mg/kg).Hemodynamic 
comparisons showed that group K had significant raise in MAP (p=0.00) 
after induction, while group P had significantly higher heart rate (p= 
0.040). 
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SUMMARY: 
From this prospective single blind study conducted on 80 patients 
undergoing elective surgery, we tried to evaluate the effect of the 
Ketamine on the onset time and intubating conditions of Rocuronium 
bromide. The summary of our findings are   
1) The demographic profile such as age , sex ,height ,weight and BMI 
were comparable between the groups. 
2) The indices that measure the difficulty of an intubation such as 
MMS, Cormack Lehane grading and POGO score were 
comparable between the groups. 
3) The mean time of onset of neuromuscular blockade was 93.48± 
33.74 seconds in Ketamine group versus 127.50±48.75 seconds in 
saline group. It was statistically significant with a ‘p’value of0.001.  
4) The percentage of acceptable intubating conditions in Ketamine 
group was 87.5% and in saline group was 80 %. Both the groups 
were comparable. 
5) When compared to the baseline values, the mean arterial pressure 
at induction was better maintained in Ketamine group than in 
saline group.  
6) Arterial blood pressure and the heart rate at other times were 
comparable between the groups. 
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CONCLUSION: 
 
From our study we conclude that administration of low dose Ketamine 
before induction reduces the onset time of Rocuronium bromide with 
stable hemodynamics. Though, acceptable intubating conditions were 
seen in 87.5 % of cases with Ketamine, we could not demonstrate a 
significant difference between the groups. 
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KETAMINE GROUP (GROUP- B) – DEMOGRAPHICS,HEART RATE,INTUBATION CONDITIONS 
S 
NO. 
NAME AGE SEX HT WT BMI ASA MMS 
HEART RATE 
TIME 
CL 
GRADE 
POGO INT-COND 
INT 
SCORE 
BASAL PREMED KET INDUCT INT 1 MIN 3 MIN 5 MIN TOTAL 
1 DEVARAJ 52 M 156 50 20.5 1 1 94 88 92 102 112 98 90 86 148 II B 50 GOOD 7 
2 FATHIMA 35 F 153 60 25.6 1 1 88 89 102 112 120 116 114 110 145 I 100 FAIR 5 
3 THIGAMMA 60 F 157 60 24.3 1 1 76 68 84 102 110 104 100 88 93 I 100 EXCELLENT 8 
4 ARAVIND 20 M 162 48 18.3 1 1 90 86 82 88 86 82 84 87 144 I 100 GOOD 7 
5 BALAN 42 M 159 56 22.2 1 1 90 76 72 76 112 128 126 96 153 I 100 GOOD 7 
6 MANOJ 23 M 166 60 21.8 1 1 80 70 78 76 90 86 80 84 88 II A 75 EXCELLENT 9 
7 KUMAR 40 M 162 55 21.0 1 1 92 102 116 106 126 104 102 92 74 I 100 GOOD 7 
8 MARIA 35 F 162 57 21.7 1 2 78 80 92 97 98 96 97 97 51 I 100 EXCELLENT 9 
9 AMIRTHARAJ 22 M 165 75 27.5 1 2 97 104 97 92 124 102 104 108 86 II B 25 GOOD 7 
10 KALPANA 26 F 146 45 21.1 1 2 104 102 106 96 116 102 96 90 69 I 100 EXCELLENT 8 
11 MADHUBALA 20 F 155 50 20.8 1 2 90 76 82 86 88 84 92 90 78 I 100 EXCELLENT 9 
12 VEERAMMAL 36 F 156 53 21.8 1 2 90 100 102 108 100 104 106 102 103 II A 100 FAIR 6 
13 NAGAJYOTHI 45 F 152 53 22.9 1 2 85 77 89 92 105 110 98 82 77 II A 66 GOOD 7 
14 DEVI 27 F 142 45 22.3 1 2 92 98 95 102 116 101 102 102 67 I 100 FAIR 5 
15 JOHN JAYASEELAN 47 M 153 49 20.9 1 2 92 90 114 106 118 108 104 90 84 I 100 EXCELLENT 9 
16 SELVAKUMARI 35 F 157 45 18.3 1 2 102 96 98 101 106 82 88 89 141 IIA 66 EXCELLENT 9 
17 SUCHITRA 27 F 155 51 21.2 1 2 96 88 82 89 98 86 84 78 172 i 100 EXCELLENT 9 
18 RAMA 45 F 158 55 22.0 2 2 82 78 88 84 92 90 86 84 93 IIA 66 EXCELLENT 9 
19 VASANTHKUMAR 18 M 153 55 23.5 2 2 78 76 86 84 108 96 92 88 70 IIA 75 FAIR 4 
20 TAMILSELVI 40 F 162 55 21.0 1 1 76 78 75 78 82 97 92 80 61 I 100 EXCELLENT 9 
21 RAJESWARI 30 F 161 52 20.1 1 2 86 76 85 88 92 97 90 80 77 I 100 EXCELLENT 9 
22 VIJAYA 38 F 157 55 22.3 1 2 85 86 90 96 112 120 104 90 145 IIA 75 EXCELLENT 9 
23 SANGEETHA 50 F 152 50 21.6 1 1 84 88 88 105 110 88 82 80 79 I 100 EXCELLENT 9 
24 SANJIVI 18 M 163 52 19.6 1 1 86 94 90 94 81 82 78 76 110 1 100 EXCELLENT 9 
25 ANU 22 F 159 53 21.0 1 2 89 90 91 96 106 90 98 100 87 I 100 EXCELLENT 9 
26 ASEENA BEGAM 30 F 154 45 19.0 1 2 89 90 92 97 96 90 90 94 62 1 100 EXCELLENT 9 
27 CHITRA 34 F 165 57 20.9 1 2 83 85 92 90 104 110 100 105 57 1 100 EXCELLENT 9 
28 KARTHIK 18 M 170 57 19.7 1 2 96 94 86 88 82 92 88 82 152 1 100 EXCELLENT 9 
29 MALARKODI 18 F 153 45 19.2 1 2 85 89 102 96 104 102 86 89 64 1 100 GOOD 6 
30 RAJESWARI 30 F 165 62 22.8 1 2 84 79 79 76 86 84 76 67 77 1 100 EXCELLENT 9 
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31 MUTHULAKSHMI 24 F 163 59 22.2 2 2 72 70 82 112 106 100 90 89 60 1 100 EXCELLENT 9 
32 REKHA 34 F 152 50 21.6 1 2 72 76 84 100 106 104 82 83 51 IIB 35 GOOD 6 
33 SHANTHI 40 F 167 60 21.5 1 2 69 70 86 86 102 108 88 89 59 IIA 75 GOOD 7 
34 PRAKASH 19 M 172 63 21.3 1 1 68 59 63 66 102 86 80 66 57 I 100 EXCELLENT 9 
35 SUBBULAKSHMI 19 F 149 42 18.9 1 1 89 85 86 87 92 102 88 88 126 IIA 75 EXCELLENT 9 
36 SARAVANAN 19 M 171 60 20.5 1 2 72 76 84 76 79 92 86 78 93 I 100 EXCELLENT 9 
37 SURESH 35 M 183 70 20.9 1 1 82 82 84 78 76 82 78 62 82 1 100 GOOD 5 
38 AIYASH 45 M 164 54 20.1 1 2 82 88 82 96 98 92 97 87 84 1 100 EXCELLENT 9 
39 MADAVAN 40 M 179 69 21.5 1 2 78 80 64 66 63 66 72 69 130 IIA 66 FAIR 5 
40 PARANTHAMAN 20 M 165 60 22.0 1 3 76 82 74 72 92 82 78 63 90 IIA 66 EXCELLENT 9 
 
KETAMINE GROUP (GROUP- B) –HEMODYNAMICS 
S 
NO. 
NAME 
SYSTOLIC BLOOD PRESSURE DIASTOLIC BLLOD PRESSURE MEAN ARTERIAL PRESSURE 
BASAL PREMED KET INDUCT INT 
1 
MIN 
3 
MIN 
5 
MIN 
BASAL PREMED KET INDUCT INT 
1 
MIN 
3 
MIN 
5 
MIN 
BASAL PREMED KET INDUCT INT 
1 
MIN 
3 
MIN 
5 
MIN 
1 DEVARAJ 150 140 146 90 133 126 130 140 78 80 78 60 84 72 70 84 102 100 101 70 100 90 90 103 
2 FATHIMA 126 120 140 130 146 152 146 140 70 70 84 78 84 78 80 78 89 87 103 95 105 103 102 99 
3 THIGAMMA 130 118 126 106 110 116 132 136 72 70 70 74 78 84 78 74 91 86 89 85 89 95 96 95 
4 ARAVIND 110 102 114 126 156 140 146 142 76 64 72 74 84 78 76 78 87 77 86 91 108 99 99 99 
5 BALAN 130 124 120 106 150 144 146 124 72 60 72 78 104 98 100 78 91 81 88 87 119 113 115 93 
6 MANOJ 116 108 110 112 116 108 110 110 74 60 64 60 80 88 70 68 88 76 79 77 92 95 83 82 
7 KUMAR 130 124 144 130 164 140 146 130 72 76 70 70 110 102 88 80 91 92 95 90 128 115 107 97 
8 MARIA 127 126 130 105 104 105 110 100 80 70 76 60 76 69 70 52 96 89 94 75 85 81 83 68 
9 AMIRTHARAJ 138 140 134 140 152 144 136 114 78 85 89 78 80 70 72 60 98 103 104 99 104 95 93 78 
10 KALPANA 120 116 118 104 140 108 116 118 70 72 70 78 84 72 72 70 87 87 86 87 103 84 87 86 
11 MADHUBALA 104 108 110 112 110 108 96 96 72 72 76 76 70 76 60 62 83 84 87 88 83 87 72 73 
12 VEERAMMAL 108 104 106 91 98 96 92 97 72 70 72 64 62 64 58 65 84 81 83 73 74 75 69 76 
13 NAGAJYOTHI 120 118 119 108 150 139 120 108 70 76 72 72 104 99 86 76 87 90 88 84 119 112 97 87 
14 DEVI 104 102 106 92 134 110 98 102 76 76 70 56 74 70 64 76 85 85 82 68 94 83 75 85 
15 
JOHN 
JAYASEELAN 
130 126 130 132 162 142 132 126 70 74 84 78 110 94 76 74 90 91 99 96 127 110 95 91 
16 SELVAKUMARI 120 104 104 126 142 140 126 105 78 78 84 70 104 98 70 76 92 87 91 89 117 112 89 86 
17 SUCHITRA 120 104 110 104 132 105 108 104 72 80 78 76 84 76 78 72 88 88 89 85 100 86 88 83 
18 RAMA 104 108 130 138 142 138 126 124 76 72 76 99 102 100 96 90 85 84 94 112 115 113 106 101 
19 VASANTHKUMAR 104 108 112 110 124 108 96 92 78 84 70 76 70 70 70 76 87 92 84 87 88 83 79 81 
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20 TAMILSELVI 120 124 120 112 108 120 124 122 70 82 80 84 84 82 80 86 87 96 93 93 92 95 95 98 
21 RAJESWARI 110 114 110 112 108 110 104 102 70 72 70 72 70 70 70 76 83 86 83 85 83 83 81 85 
22 VIJAYA 110 114 112 96 142 130 120 108 72 78 70 54 108 90 74 70 85 90 84 68 119 103 89 83 
23 SANGEETHA 98 96 94 88 118 96 90 92 72 70 72 56 88 76 70 76 81 79 79 67 98 83 77 81 
24 SANJIVI 102 108 102 108 122 124 128 130 78 84 76 70 80 78 76 84 86 92 85 83 94 93 93 99 
25 ANU 108 122 124 129 128 124 130 140 70 76 70 87 78 78 76 95 83 91 88 101 95 93 94 110 
26 ASEENA BEGAM 96 98 110 102 114 108 88 89 56 60 74 78 72 76 70 72 69 73 86 86 86 87 76 78 
27 CHITRA 148 120 127 128 126 136 122 130 100 80 84 87 85 88 84 82 116 93 98 101 99 104 97 98 
28 KARTHIK 114 110 108 110 124 148 118 116 86 76 74 70 86 84 74 73 95 87 85 83 99 105 89 87 
29 MALARKODI 118 126 123 126 123 140 136 120 70 76 78 84 86 78 78 76 86 93 93 98 98 99 97 91 
30 RAJESWARI 110 112 124 102 110 114 106 93 70 72 76 70 72 70 70 62 83 85 92 81 85 85 82 72 
31 MUTHULAKSHMI 126 120 136 109 122 146 96 99 72 56 72 70 90 84 54 58 90 77 93 83 101 105 68 72 
32 REKHA 126 120 134 96 114 119 120 119 78 72 72 58 80 90 70 83 94 88 93 71 91 100 87 95 
33 SHANTHI 104 110 126 114 144 140 126 128 76 72 72 70 80 88 80 72 85 85 90 85 101 105 95 91 
34 PRAKASH 120 110 114 78 110 104 106 100 80 70 72 50 72 70 72 54 93 83 86 59 85 81 83 69 
35 SUBBULAKSHMI 108 104 110 116 130 126 124 114 78 76 72 72 70 78 72 78 88 85 85 87 90 94 89 90 
36 SARAVANAN 110 116 118 110 143 130 124 120 76 74 76 70 86 88 92 90 87 88 90 83 105 102 103 100 
37 SURESH 142 140 138 126 142 138 110 118 76 72 70 72 108 72 70 74 98 95 93 90 119 94 83 89 
38 AIYASH 138 140 142 140 148 146 140 143 76 84 78 70 92 84 78 98 97 103 99 93 111 105 99 113 
39 MADAVAN 140 110 110 116 113 110 115 116 84 70 72 78 72 70 76 77 103 83 85 91 86 83 89 90 
40 PARANTHAMAN 122 124 120 110 140 123 120 130 70 70 76 70 102 76 72 90 87 88 91 83 115 92 88 103 
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SALINE GROUP (GROUP- A) – DEMOGRAPHICS,HEART RATE,INTUBATION CONDITIONS 
S 
NO. 
NAME AGE SEX HT WT BMI ASA MMS 
HEART RATE 
TIME 
CL 
GRADE 
POGO INT-COND 
INT 
SCORE 
BASAL PREMED SALINE INDUCT INT 1 MIN 3 MIN 
5 
MIN 
TOTAL 
1 SUGANTHI 41 F 157 55 22.3 2 2 82 89 88 68 78 89 76 68 60 I 100 GOOD 7 
2 SELVI 38 F 153 50 21.4 2 2 84 92 90 93 120 112 108 99 225 I 100 FAIR 5 
3 GOWRI 34 F 165 65 23.9 1 1 87 80 82 96 112 102 98 90 147 I 100 EXCELLENT 9 
4 RAJA 36 M 151 45 19.7 1 1 74 76 72 123 120 104 106 96 147 I 100 EXCELLENT 9 
5 REKHA 18 F 153 45 19.2 1 2 74 76 74 120 126 108 94 88 83 IIA 50 FAIR 5 
6 PAVITHRA 18 F 147 40 18.5 1 1 78 86 82 86 106 102 92 86 92 I 100 GOOD 7 
7 CHINNAPONNU 40 F 154 50 21.1 2 2 84 84 86 120 126 108 84 72 84 IIA 50 GOOD 7 
8 LOURD MARY 40 F 175 85 27.8 1 2 98 86 82 86 106 102 92 86 77 I 100 EXCELLENT 9 
9 CHANDRAIAH 50 M 167 60 21.5 1 1 86 90 92 88 110 106 84 82 170 I 100 EXCELLENT 9 
10 KOTHANDAN 52 M 163 56 21.1 1 2 68 72 70 86 82 84 82 78 149 IIA 66 EXCELLENT 8 
11 RAJESWARI 40 F 164 61 22.7 1 2 106 98 88 86 92 88 86 84 170 I 100 EXCELLENT 9 
12 KAMATCHI 50 F 179 75 23.4 1 1 68 66 62 66 72 92 62 61 63 IIA 66 GOOD 7 
13 KALAIARASI 40 F 171 65 22.2 1 3 64 82 84 75 92 96 76 76 65 I 100 EXCELLENT 9 
14 AMALU 30 F 162 57 21.7 1 1 81 79 78 82 80 92 76 74 77 IIB 33 EXCELLENT 9 
15 DEVI 50 F 149 50 22.5 1 2 96 88 86 76 114 96 84 80 198 IIB 33 EXCELLENT 9 
16 SAKTHIVEL 31 M 162 55 21.0 1 2 89 92 86 80 116 92 88 84 96 IIA 66 FAIR 5 
17 SEETHA 26 F 155 52 21.6 1 2 54 82 78 82 96 84 86 87 127 I 100 EXCELLENT 9 
18 KALAISELVI 35 F 146 45 21.1 1 1 92 96 94 86 130 104 104 90 210 I 100 EXCELLENT 9 
19 SURESH 20 M 162 58 22.1 1 1 76 72 86 89 102 76 78 74 113 IIA 66 FAIR 5 
20 VINOTHKUMAR 28 M 173 70 23.4 1 2 84 78 76 86 122 126 108 92 108 I 100 EXCELLENT 9 
21 RAHUL 26 M 164 55 20.4 1 1 77 82 84 78 70 76 82 84 158 I 100 EXCELLENT 9 
22 AMUDHA 57 F 160 57 22.3 1 2 86 92 96 89 102 86 88 84 213 I 100 EXCELLENT 9 
23 SHEELA 35 F 155 52 21.6 1 2 92 101 105 96 113 105 103 98 92 IIIA 0 FAIR 5 
24 POUNAMMAL 45 F 153 52 22.2 1 2 87 86 86 73 106 102 78 75 222 IIB 66 FAIR 5 
25 SENTHILNATHAN 40 M 182 72 21.7 1 1 92 90 102 106 128 108 96 80 143 I 100 EXCELLENT 9 
26 SASHI 30 F 152 46 19.9 1 1 86 88 92 82 121 113 98 96 103 IIA 66 GOOD 7 
27 RAJENDIRAN 44 M 169 69 24.2 1 2 71 69 75 71 92 97 91 85 159 I 100 EXCELLENT 8 
28 MUTHU 37 M 178 80 25.2 1 2 98 82 90 110 108 116 98 90 92 IIB 33 EXCELLENT 8 
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29 NIROSHA 21 F 152 55 23.8 1 1 86 82 90 85 110 111 108 84 132 I 100 GOOD 7 
30 MUTHUMANIKANDAN 20 M 159 52 20.6 1 1 86 88 84 92 86 96 89 80 170 i 100 EXCELLENT 9 
31 GOKUL 20 M 157 51 20.7 1 1 92 89 104 89 106 110 108 105 141 I 100 EXCELLENT 9 
32 MURALI 19 M 163 58 21.8 1 2 60 58 62 49 82 78 62 61 106 I 100 EXCELLENT 9 
33 SOWMIYA 16 F 155 48 20.0 1 1 82 78 104 96 126 110 81 86 210 I 100 EXCELLENT 9 
34 MAHENDRAN 26 M 156 60 24.7 1 1 88 86 88 84 124 116 94 80 91 IIA 66 GOOD 7 
35 ARCHANA 18 F 145 47 22.4 1 2 85 87 92 102 110 108 104 106 72 IIA 66 GOOD 7 
36 JAYALAKSHMI 18 F 153 50 21.4 1 3 82 78 84 86 92 84 78 75 143 I 100 EXCELLENT 9 
37 SANDHIYA 23 F 156 58 23.8 1 1 82 78 80 76 82 88 87 82 124 IIA 50 GOOD 7 
38 MAHESH 19 M 167 58 20.8 1 1 82 68 74 86 116 110 81 86 110 I 100 FAIR 5 
39 SUBRAMANI 36 M 154 60 25.3 1 1 74 65 66 91 95 95 94 92 50 I 100 GOOD 6 
40 ELAYVENDHAN 28 M 173 70 23.4 1 2 84 78 76 86 122 126 108 92 108 I 100 FAIR 5 
 
SALINE GROUP (GROUP- A) – HEMODYNAMICS 
S NO. NAME 
SYSTOLIC BLOOD PRESSURE DIASTOLIC BLLOD PRESSURE MEAN ARTERIAL PRESSURE 
BASAL PREMED SALINE INDUCT INT 
1 
MIN 
3 
MIN 
5 
MIN 
BASAL PREMED SALINE INDUCT INT 
1 
MIN 
3 
MIN 
5 
MIN 
BASAL PREMED SALINE INDUCT INT 
1 
MIN 
3 
MIN 
5 
MIN 
1 SUGANTHI 140 129 132 139 136 140 120 110 80 64 76 100 110 102 86 72 100 86 95 113 119 115 97 85 
2 SELVI 108 107 115 86 88 84 96 111 85 85 81 50 56 52 68 82 93 92 92 62 67 63 77 92 
3 GOWRI 110 114 118 96 130 130 124 126 72 76 70 64 76 70 78 72 85 89 86 75 94 90 93 90 
4 RAJA 114 110 114 85 132 116 110 118 87 85 90 69 78 72 78 84 96 93 98 74 96 87 89 95 
5 REKHA 116 114 110 86 164 126 124 122 70 72 72 54 70 72 70 70 85 86 85 65 101 90 88 87 
6 PAVITHRA 150 146 147 132 138 146 140 140 80 74 78 70 90 84 80 80 103 98 101 91 106 105 100 100 
7 CHINNAPONNU 116 104 108 90 144 126 124 122 70 72 72 54 70 72 70 70 85 83 84 66 95 90 88 87 
8 LOURD MARY 150 146 152 132 150 170 146 140 80 74 68 73 100 104 74 70 103 98 96 93 117 126 98 93 
9 CHANDRAIAH 116 118 110 104 150 148 130 128 70 72 80 76 114 108 90 84 85 87 90 85 126 121 103 99 
10 KOTHANDAN 120 156 150 116 124 123 120 125 99 90 86 78 72 76 80 90 106 112 107 91 89 92 93 102 
11 RAJESWARI 124 146 126 124 126 134 130 110 86 92 78 72 90 88 80 72 99 110 94 89 102 103 97 85 
12 KAMATCHI 158 140 142 124 120 103 88 103 64 76 78 72 76 70 64 76 95 97 99 89 91 81 72 85 
13 KALAIARASI 106 116 120 108 122 124 123 126 84 72 72 76 84 78 80 91 91 87 88 87 97 93 94 103 
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14 AMALU 124 108 104 102 96 110 124 130 76 68 72 70 54 70 70 72 92 81 83 81 68 83 88 91 
15 DEVI 160 140 142 126 160 140 139 132 88 84 90 72 102 80 78 76 112 103 107 90 121 100 98 95 
16 SAKTHIVEL 130 128 128 96 118 164 124 130 84 78 76 54 76 84 78 78 99 95 93 68 90 111 93 95 
17 SEETHA 110 121 116 89 112 110 112 101 72 76 76 64 76 78 76 64 85 91 89 72 88 89 88 76 
18 KALAISELVI 106 110 104 98 150 144 156 143 72 70 72 64 98 110 98 70 83 83 83 75 115 121 117 94 
19 SURESH 124 110 115 80 122 98 106 103 76 72 70 56 84 54 73 70 92 85 85 64 97 69 84 81 
20 VINOTHKUMAR 128 126 124 106 158 102 96 98 72 76 70 70 96 76 54 50 91 93 88 82 117 85 68 66 
21 RAHUL 126 116 110 117 136 110 108 112 76 80 82 84 70 76 82 80 93 92 91 95 92 87 91 91 
22 AMUDHA 124 110 116 89 122 98 106 103 76 72 70 56 84 54 73 70 92 85 85 67 97 69 84 81 
23 SHEELA 116 118 126 128 140 114 110 112 80 76 74 70 84 99 80 78 92 90 91 89 103 104 90 89 
24 POUNAMMAL 105 108 106 91 150 140 128 124 82 79 80 62 72 102 70 76 90 89 89 72 98 115 89 92 
25 SENTHILNATHAN 124 126 124 120 140 120 116 124 92 78 70 76 84 70 76 72 103 94 88 91 103 87 89 89 
26 SASHI 126 120 114 109 144 117 106 110 72 70 70 58 102 81 78 70 90 87 85 75 116 93 87 83 
27 RAJENDIRAN 135 128 115 114 148 144 127 100 78 70 88 80 99 110 99 77 97 89 97 91 115 121 108 85 
28 MUTHU 130 136 142 96 140 148 136 138 78 84 86 64 110 98 96 96 95 101 105 75 120 115 109 110 
29 NIROSHA 108 110 114 98 138 144 120 115 72 76 72 64 82 98 70 72 84 87 86 75 101 113 87 86 
30 MUTHUMANIKANDAN 124 126 122 116 124 126 116 127 72 78 76 78 70 72 82 87 89 94 91 91 88 90 93 100 
31 GOKUL 126 128 124 86 144 138 130 145 70 72 80 64 80 78 70 72 89 91 95 71 101 98 90 96 
32 MURALI 126 123 122 126 144 136 123 122 78 74 70 70 110 98 76 72 94 90 87 89 121 111 92 89 
33 SOWMIYA 104 106 116 110 124 116 110 108 72 76 78 70 90 72 72 70 83 86 91 83 101 87 85 83 
34 MAHENDRAN 140 136 146 140 140 136 146 130 98 90 97 84 90 88 76 78 112 105 113 103 107 104 99 95 
35 ARCHANA 110 116 110 108 153 132 136 140 72 72 72 84 110 107 108 102 85 87 85 92 124 115 117 115 
36 JAYALAKSHMI 108 112 110 116 134 141 106 112 72 70 76 72 84 82 72 69 84 84 87 87 101 102 83 83 
37 SANDHIYA 110 116 112 108 138 120 120 114 72 70 70 64 78 62 68 72 85 85 84 79 98 81 85 86 
38 MAHESH 104 106 118 112 114 116 107 110 62 72 76 90 70 72 72 68 76 83 90 97 85 87 84 82 
39 SUBRAMANI 148 134 130 128 130 130 128 143 89 92 90 92 100 107 90 90 109 106 103 104 110 115 103 108 
40 ELAYVENDHAN 128 126 124 106 158 102 96 98 72 76 70 70 96 76 54 50 91 93 88 82 117 85 68 66 
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PROFORMA 
 
 
NAME:                                                 AGE:             SEX:                       I.P. NO. 
 
DIAGNOSIS:                                                                WT:                    MMS CLASS:   
 
SURGERY PERFORMED:                                              TEST DRUG: 
 
HEMODYNAMICS: 
 
 HR BP 
BASELINE   
AFTER PREMEDICATION   
AFTER TEST DRUG   
AFTER INDUCTION   
AFTER INTUBATION   
1 MIN   
3 MIN   
5 MIN   
            
TIME: 
 
TEST DRUG                           SEC 
TIME FOR DISAPPEARANCE OF TI IN TOF OR STS                           SEC 
x 
 
                            
 
 
INTUBATING CONDITIONS: 
 
 CORMACK LEHANNE GRADE –  
 
 POGO SCORE –  
 
 GRADING OF INTUBAING CONDITIONS BY COOPER, ET AL 
 
 
SCORE  JAW RELAXATION  VOCAL CORDS  RESPONSE TO INTUBATION 
0  POOR  CLOSED  SEVERE 
COUGHING/BUCKING 
1 MINIMAL  CLOSING  MILD COUGHING 
2 MODERATE  MOVING SLIGHTLY  DIAPHRAGMATIC 
MOVEMENT 
3 GOOD  OPEN  NONE 
    
TOTAL 
SCORE 
 INTUBATING 
CONDITIONS 
 
 
                                                                           Score  8-9 = Excellent,  6-7 = Good,  3-5 = Fair,  0-2 =Poor 
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INFORMATION TO PARTICIPANTS 
 
Investigator                     : Dr.Naveen Kumar .D 
 
Name of the Participant: 
 
Title    
   The Effect Of Ketamine  On The Onset Time And The  Intubating Conditions Of  Rocuronium 
Bromide 
 You are invited to take part in this research study. We have got approval from the IEC. Your are 
asked to participate because you satisfy the eligibility criteria .We want to  study the  effect of 
ketamine  on the intubating  conditions of propofol rocuronium induction. 
. 
What is the Purpose of the Research: 
This is  done  to study the effect of ketamine  on the intubating  conditions and the onset time of 
propofol rocuronium induction on elective surgeries. The onset time of a neuromuscular blocking 
drug is an important factor in determining the speed and ease with which the trachea can be 
intubated especially for rapid sequence induction for which suxamethonium is used which can cause 
complications in certain conditions like hyperkalemia,cholinesterase deficiency,burns,penetrating 
eye injury,allergic reactions. Nevertheless, speed of onset of rocuronium is dose-dependent and high 
doses are associated with a long duration of action. We hypothesized that the addition of ketamine 
to a propofol induction would improve intubating conditions after rocuronium while shortening the 
onset time of neuromuscular block thus avoiding the undue side effects of suxamethonium and also 
high dose of rocuronium. 
 
The Study Design: 
                         to study the effects of ketamine  on the intubating  conditions of propofol rocuronium 
induction on elective surgeries. You will be allocated into one of the two groups after getting 
informed consent.after premedicating with drugs to reduce your anxiety we will give drugs to 
anesthetise you and get trachea intubated.various parameters such as heart rate, bp etc will be 
measured. 
Benefits: 
 With ketamine , there would be better intubating conditions with shorter onset time  and 
shorter duration of muscle relaxant as it would be useful in short duration surgeries. It would be 
useful in avoiding unwanted side effects of suxamethonium. The fall in BP that can occur following a 
normal induction is offset by use ketamine  
xii 
 
 
Discomforts and risks: 
                    Raise in heart rate and blood pressure can occur..If heart rate increases then we giveinj 
xylocard or inj.esmolol. there is a possibility of emergence delirium in few patients which can be 
readily treated with midazolam. There is risk of cannot ventilate and cannot intubate situation which 
can occur in 0.1% of population where emergency airway may be placed like laryngeal mask airway, 
tracheostomy or cricothyroidotomy  
This intervention has been shown to be well tolerated as shown by previous studies. And if you do 
not want to participate you will have alternative of setting the standard treatment and your safety is 
our prime concern. 
 
Time : 
Date : 
Place : 
Signature / Thumb Impression of Patient 
Patient Name: 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
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                                                      PATIENT CONSENT FORM 
 
Study title         
the effect of ketamine  on the onset time and the intubating conditions of  rocuronium bromide 
                                        
Study centre    :           Department of Anaesthesiology 
                                       Institute of Anesthesiology and critical care, 
                                       Madras Medical College 
                                       Chennai 600003  
           
 
 
Participant name :                                                Age:                         Sex:                                I.P.No: 
 
                  
                        I confirm that i have understood the purpose of procedure for the above study . i have 
the opportunity to ask the question and all my questions and doubts have been answered to my 
satisfaction. 
                      
                        I have been explained about the pitfall in the procedure.  I have been explained about 
the safety,advantage and disadvantage of the technique. 
 
                        I understand that my participation in the study is voluntary and that i am free to 
withdraw at anytime without giving any reason. 
 
                        I understand that investigator ,regulatory authorities and the ethics committee will not 
need my permission to look at my health records both in respect to current study and any further 
research that may be conducted in relation to it, even if i withdraw from the study . I understand 
that my identity will not be revealed in any information released to third parties or published , 
unless as required under the law . I agree not to restrict the use of any data or results that arise from 
the study . 
 
Time:          
 
Date:                                                                                             signature / thumb impression of patient  
 
Place:                                                                                            patient name: 
 
Signature of the investigator: 
 
Name of the investigator: 
